These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 406909)

  • 21. A comparison of the effect of flurbiprofen on prostaglandin synthetase from human rheumatoid synovium and enzymatically active animal tissues.
    Crook D; Collins AJ; Rose AJ
    J Pharm Pharmacol; 1976 Jun; 28(6):535. PubMed ID: 7661
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative evaluation of the inhibitory effects of aspirin-like drugs on prostaglandin production by human platelets and synovial tissue.
    Patrono C; Ciabattoni G; Greco F; Grossi-Belloni D
    Adv Prostaglandin Thromboxane Res; 1976; 1():125-31. PubMed ID: 826138
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioimmune assay of human platelet prostaglandin synthetase.
    Roth GJ; Machuga ET
    J Lab Clin Med; 1982 Feb; 99(2):187-96. PubMed ID: 6801166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor.
    Dohi M; Sakata Y; Seki J; Namikawa Y; Fujisaki J; Tanaka A; Takasugi H; Motoyama Y; Yoshida K
    Eur J Pharmacol; 1993 Oct; 243(2):179-84. PubMed ID: 8276067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylation of prostaglandin synthetase by aspirin. Purification and properties of the acetylated protein from sheep vesicular gland.
    Roth GJ; Stanford N; Jacobs JW; Majerus PW
    Biochemistry; 1977 Sep; 16(19):4244-8. PubMed ID: 409429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salicylates and 12-lipoxygenase activity in human washed platelets.
    Radomski M; Michalska Z; Marcinkiewicz E; Gryglewski RJ
    Pharmacol Res Commun; 1986 Nov; 18(11):1015-30. PubMed ID: 3797446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CGP 28,238, a new potent nonsteroidal anti-inflammatory agent: its relation to arachidonic acid metabolism.
    Hirschelmann R; Hentschel M; Giessler J; Rickinger O
    Agents Actions; 1991 Jan; 32(1-2):54-5. PubMed ID: 1905461
    [No Abstract]   [Full Text] [Related]  

  • 28. Light emission during the action of prostaglandin synthetase.
    Marnett LJ; Wlodawer P; Samuelsson B
    Biochem Biophys Res Commun; 1974 Oct; 60(4):1286-94. PubMed ID: 4424375
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.
    O'Kane P; Xie L; Liu Z; Queen L; Jackson G; Ji Y; Ferro A
    Cardiovasc Res; 2009 Jul; 83(1):123-30. PubMed ID: 19377066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin.
    Stanford N; Roth GJ; Shen TY; Majerus PW
    Prostaglandins; 1977 Apr; 13(4):669-75. PubMed ID: 404672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.
    Lefort J; Vargaftig BB
    Br J Pharmacol; 1978 May; 63(1):35-42. PubMed ID: 647162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.
    Tempero KF; Cirillo VJ; Steelman SL
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):31S-36S. PubMed ID: 328032
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.
    Li X; Fries S; Li R; Lawson JA; Propert KJ; Diamond SL; Blair IA; FitzGerald GA; Grosser T
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16830-5. PubMed ID: 25385584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
    Smith WL; DeWitt DL; Shimokawa T; Kraemer SA; Meade EA
    Stroke; 1990 Dec; 21(12 Suppl):IV24-8. PubMed ID: 2175460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of protein binding and pharmacokinetics in the lack of correlation between in vitro inhibition of PG-synthetase and in vivo antiinflammatory activity of a homologous series of nonsteroidal antiinflammatory compounds.
    Ceserani R; Ferrari M; Goldaniga G; Moro E; Buttinoni A
    Life Sci; 1977 Jul; 21(2):223-9. PubMed ID: 407406
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification and characterization of sheep platelet cyclo-oxygenase. Acetylation by aspirin prevents haemin binding to the enzyme.
    Boopathy R; Balasubramanian AS
    Biochem J; 1986 Oct; 239(2):371-7. PubMed ID: 3101664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of the animal and clinical pharmacology of diflunisal.
    Davies RO
    Pharmacotherapy; 1983; 3(2 Pt 2):9S-22S. PubMed ID: 6344042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diflunisal, a new-acting analgesic and prostaglandin inhibitor: effect of concomitant acetylsalicylic acid therapy on ototoxicity and on disposition of both drugs.
    Schulz P; Perrier CV; Ferber-Perret F; VandenHeuvel WJ; Steelman SL
    J Int Med Res; 1979; 7(1):61-8. PubMed ID: 311303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of prostaglandin synthetase by F-776, 5-(4-chlorophenyl)-beta-hydroxy-2-furanpropanoic acid, a new anti-inflammatory/analgesic compound.
    Huang CT; Ellis KO
    Biochem Pharmacol; 1981 Nov; 30(21):3008-9. PubMed ID: 6797436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.